Author

E. Macri

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Assay:ChIP-seq· 1 Research Focus:chromatin & epigenetic regulation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Organism:mouse· 1 Approach:statistical model· 1

Frequent Co-Authors

A. Mai· 1 shared A. Renzini· 1 shared I. Salvatori· 1 shared L. Tucciarone· 1 shared M. De Bardi· 1 shared M. Picozza· 1 shared P. L. Puri· 1 shared S. Consalvi· 1 shared

Activity by Year

2021-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

A. Mai

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Partial resistance to HDAC inhibitors in FAPs of dystrophic muscles at late stages of disease is associated to epigenetic and transcriptional features of cellular senescence.

S. Consalvi, L. Tucciarone, E. Macri, M. De Bardi, M. Picozza, I. Salvatori, A. Renzini, S. Valente, A. Mai, V. Moresi, P. L. Puri

This study shows that HDAC inhibitors are less effective in late-stage DMD muscle FAPs due to senescence-related epigenetic changes that resist reversal.

bioRxiv · Apr 26, 2021 · PreprintPharmacology & Toxicology